Urogen Pharma (URGN) delivered earnings and revenue surprises of 34.52% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers...
Vous n'êtes pas connecté
AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of 3,700% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Urogen Pharma (URGN) delivered earnings and revenue surprises of 34.52% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers...
GDEV Inc. (GDEV) delivered earnings and revenue surprises of 107.89% and 6.56%, respectively, for the quarter ended September 2024. Do the numbers...
GDEV Inc. (GDEV) delivered earnings and revenue surprises of 107.89% and 6.56%, respectively, for the quarter ended September 2024. Do the numbers...
Aadi Bioscience (AADI) delivered earnings and revenue surprises of 0% and 10.11%, respectively, for the quarter ended September 2024. Do the numbers...
Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of 8.75% and 2.36%, respectively, for the quarter ended September 2024. Do the...
AnaptysBio (ANAB) delivered earnings and revenue surprises of 33.72% and 279.19%, respectively, for the quarter ended September 2024. Do the numbers...
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the...
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -11.11% and 12.30%, respectively, for the quarter ended September 2024. Do the...
Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 7.31%, respectively, for the quarter ended September 2024. Do the numbers hold...
BioLife Solutions (BLFS) delivered earnings and revenue surprises of 77.78% and 21.98%, respectively, for the quarter ended September 2024. Do the...